Ratings by H.C. Wainwright (Pat Trucchio)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/2/2026 Bright Minds Biosciences Inc. DRUG Maintain Buy
(Buy)
 
 
  Details
5/26/2026 Oncolytics Biotech ONCY Maintain Buy
(Buy)
 
 
  Details
4/10/2026 Oncolytics Biotech ONCY Maintain Buy
(Buy)
 
 
  Details
3/5/2026 Bright Minds Biosciences Inc. DRUG Maintain Buy
(N/A)
 
 
  Details
12/31/2025 Bright Minds Biosciences Inc. DRUG Maintain Buy
(Buy)
 
 
  Details
11/17/2025 Oncolytics Biotech ONCY Maintain Buy
(N/A)
 
 
  Details
11/17/2025 Cybin Inc. CYBN Maintain Buy
(N/A)
 
 
  Details
11/11/2025 Bright Minds Biosciences Inc. DRUG Maintain Buy
(Buy)
 
 
  Details
9/15/2025 Bright Minds Biosciences Inc. DRUG Maintain Buy
(Buy)
 
 
  Details
8/20/2025 Bright Minds Biosciences Inc. DRUG Maintain Buy
(Buy)
 
 
  Details
8/19/2025 Cybin Inc. CYBN Maintain Buy
(Buy)
 
 
  Details
7/10/2025 Oncolytics Biotech ONCY Maintain Buy
(Buy)
 
 
  Details
2/20/2025 Bright Minds Biosciences Inc. DRUG Maintain Buy
(Buy)
 
 
  Details
2/13/2025 Cybin Inc. CYBN Maintain Buy
(N/A)
 
 
  Details
2/3/2025 Oncolytics Biotech ONCY Maintain Buy
(Buy)
 
 
  Details
1/28/2025 Cybin Inc. CYBN Maintain Buy
(Buy)
 
 
  Details
1/10/2025 Bright Minds Biosciences Inc. DRUG New Coverage Buy
(N/A)
41.04
(66.22)
61.35% Details
11/19/2024 Cybin Inc. CYBN Maintain Buy
(Buy)
 
 
  Details
9/20/2024 Oncolytics Biotech ONCY Maintain Buy
(Buy)
 
 
  Details
8/21/2024 Oncolytics Biotech ONCY Maintain Buy
(Buy)
 
 
  Details
11/13/2023 Oncolytics Biotech ONCY Maintain Buy
(N/A)
 
 
  Details
7/15/2022 F-Star Therapeutics Inc. FSTX Downgrade Neutral
(Buy)
6.14
(7.12)
15.96% Details
11/22/2021 Cybin Inc. CYBN Maintain Buy
(N/A)
 
 
  Details
7/26/2021 Cybin Inc. CYBN New Coverage Buy
(N/A)
0.00
(8.28)
0% Details
3/1/2021 F-Star Therapeutics Inc. FSTX New Coverage Buy
(N/A)
8.27
(7.12)
-13.91% Details
2/17/2021 Oncolytics Biotech ONCY New Coverage Buy
(N/A)
3.01
(0.92)
-69.44% Details